Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

nNOS inhibitor from Astra effective in animal models of stroke, ALS

Nov. 14, 1997

T-614, a new NSAID that appears to act as a lysosomal protease inhibitor

Nov. 14, 1997

KE-298 suppresses MMP production in RA synoviocytes

Nov. 14, 1997

Selective collagenase 3 inhibitor shows promise for osteoarthritis

Nov. 14, 1997

Clinical safety and pharmacology of Vasoflux

Nov. 14, 1997

MMP inhibitors in cardiovascular medicine

Nov. 14, 1997

New formulation of amiodarone shows favorable hemodynamic effects

Nov. 13, 1997

Preclinical antiinflammatory effects demonstrated for CT-3

Nov. 13, 1997

Minocycline associated with marked long-term efficacy in early RA

Nov. 13, 1997

Alendronate and etidronate prevent steroid-induced osteoporosis

Nov. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...